Diagnostica Stago, Inc. Product Catalog 2016 - 3c

Transcription

Diagnostica Stago, Inc.
Product Catalog 2016
STA® Family of Hemostasis Analyzers
The STA® Family of
Hemostasis Analyzers
provides automation of
coagulation testing
for a variety of
laboratory situations.
Each system performs
clotting, chromogenic
and immunoassay
methodologies in
random access
mode. Because all
STA® analyzers use
the same analysis methods
and the same reagent
formulations, they offer
standardization in
the laboratory.
MODELS: AUTOMATED
STA R Max®: Automation capable, high throughput
STA Compact Max®: Moderate throughput
STA Satellite®: Low throughput
MODELS: SEMI-AUTOMATED
STart®
FEATURES
Host-query bi-directional interface
Primary tube sampling
Continuous sample access
Open reagent system
Reagent and disposable management
Reagent level detection
QC management with Levy-Jennings
Reagent and sample bar code reader
Auto re-run and auto re-dilute options
Programmable and pre-programmed options
Up to 70 on-board reagent capacity
Capacity of up to 1,000 disposable cuvettes
Multi-constituent controls and calibrator
METHODOLOGIES
Clotting - VDS™ Mechanical Clot Detection
Chromogenic - Optical density
Immunological - Optical density
STA® ASSAY MENU
PT
APTT
Fibrinogen (Clauss)
D-dimer (Quantitative)
Thrombin Time
Reptilase Time
Extrinsic Factors
Intrinsic Factors
Anti-Xa Activity
Unfractionated Heparin (UFH)
Low Molecular Weight Heparin (LMWH)
Rivaroxaban*
Apixaban*
Edoxaban*
Ecarin Chromogenic Assay (ECA-II)*
Dabigatran*
Antithrombin (AT) Activity
Antithrombin (AT) Antigen
Protein C Activity (clot-based and chromogenic)
Protein S Activity
Free Protein S Antigen
Total Protein S Antigen
VWF Antigen
Plasminogen Activity
Antiplasmin Activity
Fibrin Monomer*
Lupus Anticoagulants
DRVVT (Screen and Confirm)
PTT-LA
Staclot LA
*(research use only; not for use in diagnostic procedures)
2 Product Catalog 2016
Table of Contents
Section 1
Instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Section 2
Disposables & Accessories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Section 3
Screening Tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Section 4
Factor Assays . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11
Section 5
Anticoagulants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Section 6
Thrombophilia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Section 7
Fibrin Formation & Degradation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Section 8
Fibrinolysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Section 9
Primary Hemostasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Section 10
Control Plasmas. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Section 11
Calibrators. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Section 12
Auxiliary Reagents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Section 13
Quality & Compliance Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Section 14
Stago Added Value on Request (SAVOR™). . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Section 15
Thrombin Generation Research Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Section 16
Ecarin Chromogenic Assay (ECA) Products . . . . . . . . . . . . . . . . . . . . . . . . . 25
Section 17
Flow Cytometry Research Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
Section 18
Research Kits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Section 19
Research Components . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Terms & Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
Main Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37-38
For the most up-to-date information on all our products, contact the
Diagnostica Stago, Inc. Marketing Dept. at 800-222-COAG or visit our
website at www.stago-us.com.
PRODUCT AVAILABILITY: Most clinical reagents are available within 5 days
after receipt of order. However if a sequestered lot of reagent is required,
please contact Sales Administration for availability.
For availability of research products, please contact Sales Administration
at 800-222-COAG, option 3. Research products not in stock may require
a 60-day notice prior to availability.
1
Instruments (continued)
Section 1
CAT. NO.
PRODUCT/ DESCRIPTION
59010
STA R Max® Hemostasis System with Cap Piercing
59013
STA R Max® Hemostasis System
Fully Automated, High-Throughput Hemostasis Analyzer (Automation-Capable)
Fully Automated, High-Throughput Hemostasis Analyzer (Automation-Capable)
The newest member of the Max Generation family of hemostasis analyzers, the STA R Max® is a high-volume, high-efficiency
analyzer that embodies Stago’s standardization of methodology, software, reagents, and consumables. Built on the most reliable
platform in the industry with an expansive test menu, the STA R Max® is the perfect hemostasis partner for high-volume and
reference laboratories performing routine and specialty assays.
Interference free Viscosity-based Detection System (VDS), exclusive to Stago, is at the heart of the STA R Max® providing
maximum sensitivity for weak clot detection and insensitivity to interferences ensuring reliability of results. The STA R Max®
enhances efficiency with features including the largest sample capacity in the industry and true STAT sample priority.
Optimized random access test management provides maximum throughput for routine and specialty coagulation testing.
With the most TLA connections worldwide, the STA-R® family of analyzers is the industry leader for total laboratory automation
(TLA) connectivity and throughput.
STA Coag Expert® software integrates over fifty years of Stago coagulation expertise into every STA R Max® system.
The STA Coag Expert® automates laboratory processes such as multi-dilution factor assays, automatic reflex testing, automatic
repeats and delta checks to ensure standardization and efficiency for routine tests as well as complex specialty assays.
Integrated accreditation tools, automated maintenance logs, integrated video tutorials and five years of patient and QC archives
stored onboard ensure industry leading tools for regulatory compliance. The STA R Max® with STA Coag Expert® equips
laboratories with an easy to use system that ensures efficient, reliable results the first time, every time.
Analyzer is provided with:
22 inch LCD touch screen flat panel monitor
USB handheld barcode reader
STA R Max® Computer Table
STA Coag Expert® Pack
RJ45 straight Ethernet cable 10M
Max Generation mouse pad
Dimensions
• Height . . . . . 49.8 inches
• Width . . . . . 48.0 inches
Uninterruptible power supply
Operator’s reference manual
Accessory kit
1-year warranty
Brother printer (optional)
• Depth . . . . . 31.6 inches
• Weight . . . . 524.7 pounds
Test Selections
200 user definable tests
Samples
• 215 sample tubes on board
• 15 sample racks/75 samples
• Continuous loading and unloading of sample racks
• True STAT capability
• Primary tube sizes accepted including pediatrics & microcontainers
• Barcode identification/Positive patient ID
• Automatic pre-dilution and dilution of samples
LIS Interface
Bi-directional host-query
Automation
Compatible with all major automation line solutions
Reagent Menu
• 70 reagent positions capable of performing a complete range of routine and
specialty tests. Contact your Stago Representative for the most current listing.
• Random loading of reagents
• Positive barcode identification
• Temperature controlled
• Precalibration for many reagents
• Automatic pre-dilution of calibrators
• Automatic Quality Control
STA R Max®
3
Section 1
CAT. NO.
58990
STA Compact Max® Coagulation System
58989
STA Compact Max® Coagulation System Cap Piercing Model
Fully Automated, Moderate-Throughput Hemostasis Analyzer
Fully Automated, Moderate-Throughput Hemostasis Analyzer
The STA Compact Max® is a fully automated, bench top hemostasis workstation capable of performing clotting, chromogenic
and immunological assays simultaneously in random access mode. The system’s unique method of sample management offers
moderate throughput and rapid processing of STAT samples with no impact on the instrument’s performance. All sample and
calibrator dilutions are performed automatically, increasing staff productivity for laboratories performing moderate-volume
routine and specialty coagulation testing.
The STA Compact Max® takes innovation to the next level by adding the state of the art STA Coag Expert® software.
The STA Coag Expert® automates laboratory processes such as multi-dilution factor assays, automatic reflex testing, automatic
repeats and delta checks to ensure standardization and efficiency for the complete analyzer testing profile. Integrated
accreditation tools, automated maintenance logs, integrated video tutorials and five years of patient and QC archives stored
onboard ensure industry leading tools for regulatory compliance. The combination of VDS methodology and the STA Coag
Expert® on the STA Compact Max® give you complete confidence in your results - the most important part of any analyzer.
• STA Coag Expert® Pack
• 22-inch LCD touch screen flat panel monitor
• Uninterruptible power supply
• Max Generation mouse pad
• Operator’s reference manual
• Accessory kit
• 1-year warranty
• Brother printer (optional)
Dimensions
• Height . . . .
• Width . . . . .
• Depth . . . . .
• Weight . . . .
27.75 inches
38.1 inches
28.73 inches
309 pounds
Test Selections
80 user-definable tests
Samples
• 96 sample tubes onboard (84 primary tube positions; 12 pediatric tube positions)
• All common tube sizes accepted including pediatrics & microcontainers
• Random loading of samples
• True STAT management
• New 4th generation cap piercing option
• Barcode identification/Positive patient ID
• Automatic pre-dilution and dilution of samples
LIS Interface
Bi-directional host-query or dynamic download
Reagent Menu
• 45 reagent positions, supporting multiple vial sizes,
capable of performing most routine and specialty tests.
Contact your Stago Representative for the most current listing.
• Random loading of reagents
• Positive barcode identification
• Temperature controlled
• Pre-calibration for all routine tests
• Automatic pre-dilution of calibrators
• Automatic Quality Control
4
STA Compact Max®
CAT. NO.
58104
STA Satellite® Hemostasis System
Section 1
Fully Automated, Low-Throughput Hemostasis Analyzer
The STA Satellite® is a fully automated benchtop hemostasis analyzer capable of performing clotting, chromogenic and
immunological assays simultaneously in random access mode. The system enables lntegrated Health Networks to standardize
patient testing results including D-dimer and Anti-Xa. Thanks to its technological innovations, STA Satellite® ensures a high
reliability level as well as ease of use, flexibility and complete security, all within a reduced footprint.
• Accessory Kit
• 1-year warranty
Dimensions
• Height . . . .
• Width . . . .
• Depth . . . .
• Weight . . .
27.4 inches
21.1 inches
25.5 inches
72 pounds
Test Selections
80 user definable tests
Samples
• 20 onboard sample capacity
• Primary tube sampling
• Removable sample carousel
• Continous sample loading
• Positive sample identification
LIS Interface
Bi-directional host-query
Other Features
• LED for chromogenic assays
• Internal barcode reader for samples and reagents
• Stago’s exclusive method of VDSTM Mechanical Clot Detection
(Viscosity-based Detection System) technology
Reagent Menu
• PT
• APTT
• Fibrinogen
• AT
• Liquid Anti-Xa (UFH and LMWH)
• D-dimer
STA Satellite®
5
Section 1
CAT. NO.
58230
STart® Hemostasis Analyzer
Benchtop Hemostasis Analyzer for Batch Testing
The STart® is a benchtop hemostasis analyzer featuring Stago’s exclusive method of VDS™ Mechanical Clot Detection
(Viscosity-based Detection System). This method eliminates interference from lipemic, icteric or other optically dense samples or
reagents. The analyzer offers programmable and pre-programmed assays with curve storage, 4 independently-timed incubation
stations, electronically-linked multiple pipettor, 40-character liquid crystal display and an internal thermal printer. Its lightweight,
compact size makes it ideal for low to medium volume batch testing or as a back-up to an optical clot detection system.
• Accessory kit
• Cabled pipette
• 1-year warranty
Dimensions
• Height . . . .
• Width . . . . .
• Depth . . . . .
• Weight . . . .
4.7 inches
16.1 inches
16.5 inches
12.5 pounds
Methodology
Clotting - Standard VDSTM Mechanical Clot Detection
Test Selections
• 17 test selections
• Preprogrammed and programmable options
Other Features
• Electronically-linked multiple pipettor for convenience and accuracy
• Integrated printer
• Four independently-timed incubation stations with audible signal
• Lightweight and compact
Reagent Menu
• PT
• APTT
• Fibrinogen
• Thrombin Time
• Reptilase Time
• Extrinsic Factors
• Intrinsic Factors
• Protein C Activity
• Protein S Activity
• PTT-LA
• Staclot® LA (Lupus Anticoagulants)
• DRVV
STart®
6
Disposables & Accessories
CAT. NO.
Section 2
CONTENTS
STA-R® Family, STA Compact® and STA Satellite® Disposables & Accessories
00741
STA®-Microtainers (for samples)
500 each
00797
STA®-Mini Reducer (5 mL vials)
100 each
00801
STA®-Maxi Reducer (10 and 15 mL vials)
100 each
00802
STA®-Microcups (for reagents)
100 each
26538
STA -Colorimetry Box Filter (metal frame)
1 each
26555
Magnetic Ball Extractor
1 each
26674
Magnetic Red Stir Bar (C.K. Prest Only)
1 each
26699
Halogen Lamp
1 each
27307
Needle # 3
1 each
27354
Needle # 2
1 each (STA Compact®)
27420
Rear Panel Air Filters
27423
Sample Microtainer Adapter (tall)
27425
Magnetic White Stir Bar
1 each
27457
Rinsing Plate Assay Air Filter (paper filter)
27458
Liquid Filter
1 each
27530
Teflon Syringe Tip and O-Ring Kit
Pack 6 each
27538
Hamilton Syringe
1 each
27543
Reduction Ring for Microcups
2 each
38125
Optical Module Fan Filter
1 each
38517
Air Filter
1 each (STA-R®)
38581
Tubing, Cap Piercing Electrovalve
38640
Liquid Cooling Glycol (Peltier System)
1 liter
38646
Needle #1
38669
STA®-Cuvettes
6 x 1000 (STA Compact® & STA-R®)
38960
STA-R® Shuttle
1 each
39002
Aluminum Microtainer Adapters
10 each (STA-R®)
39010
Tray for 15 Racks
2 each
39011
Mapping Adjustment Cuvette
1 each
39022
Needle # 1 Cap Piercing
39134
Wheel Tube Rotation
1 each
39164
Needle # 1 Cap Piercing
1 each (STA-R®)
39249
Needle # 1
1 each (STA-R®)
39250
Needle # 2
1 each (STA-R®)
88349
V2 (Pediatric Racks)
Set of 2 (STA-R®)
®
7
Section 2
CAT. NO.
Disposables & Accessories (continued)
CONTENTS
STA-R® Family, STA Compact® and STA Satellite® Disposables & Accessories (continued)
39356
Sample Needle
1 each (STA Satellite®)
39430
STA Satellite® Cuvettes
6 x 220 (STA Satellite®)
39968
Microcup Adapter
80057
Microtainer Reducer
80132
Air Filters
80203
Microtainer Rack
2 each (STA-R®)
80343
Soft Stylet
Pack of 10
88828
Reducer DIN 14
STart® Disposables & Accessories
26405
Magnetic Stir Bars (white triangular)
1 each
26441
Ball Vial (1850 / vial)
1 each
26555
Ball Extractor
1 each
26649
Thermal Paper
1 each
26729
5 mL Reduction Ring
1 each
38876
STart® Cuvettes (4 x 150)
600 / box
39476
Ball Dispenser
1 each
80109
Finnpipette
1 each
80600
Finn Tips 1.25 mL (Finnpipette Only)
100 / box
80601
Finn Tips 2.5 mL (Finnpipette Only)
100 / box
80602
Combi Tips 1.25 mL (Eppendorf Only)
100 / box
80603
Combi Tips 2.5 mL (Eppendorf Only)
100 / box
Miscellaneous Parts
8
26605
Reduction Ring DIN 14 (1.0 to 10 mL)
2 each
26610
Reagent Vial Reduction Ring DIN 18 (5.0 to 10 mL)
2 each
26681
Fuse 6.3 Amp
Pack of 10 (STA Satellite®)
26694
Fuse 15 Amp
Pack of 10
27037
Fuse 4.0 Amp
Pack of 10
27575
Fuse 6.25 Amp
Pack of 10
27576
Fuse 2.0 Amp
Pack of 10
27578
Fuse 5.0 Amp
Pack of 10
27579
Fuse 1.0 Amp
Pack of 10
27581
Fuse 3.0 Amp
Pack of 10
Section 3
Screening Tests
CAT. NO.
00605*
STA®-Neoplastine® CI 5
CONTENTS
Determination of Prothrombin Time (PT) by STA analyzers (ISI~1.8).
Freeze-dried rabbit brain thromboplastin with heparin inhibitor.
®
00606*
STA®-Neoplastine® CI Plus 5
Determination of Prothrombin Time (PT) by STA® analyzers (ISI~1.3).
00667US*
STA®-Neoplastine® CI Plus 10
Determination of Prothrombin Time (PT) by STA analyzers (ISI~1.3).
®
00595US
6 x 5 mL vials of STA® Neoplastine® CI 5
6 x 5 mL vials of Solvent
6 x 5 mL vials of STA® Neoplastine® CI Plus 5
12 x 10 mL vials of STA® Neoplastine® CI Plus 10
STA®-PTT Automate 5
12 x 5 mL vials
STA®-C.K. Prest® 5
6 x 5 mL vials of STA® C.K. Prest® 5
6 x 5 mL vials of Activator
STA®-Fibrinogen 5
12 x 5 mL vials
STA®-Thrombin 2
12 x 2 mL vials
STA®-Thrombin 10
12 x 10 mL vials
STA®-Reptilase®
6 x 2 mL vials
Determination of Activated Partial Thromboplastin Time (APTT) by
STA® analyzers. Cephalin reagent with particulate (silica) activator.
00597
Determination of Activated Partial Thromboplastin Time (APTT) by
STA® analyzers. Cephalin reagent with kaolin activator.
00674US
Quantitative determination of Fibrinogen by STA® analyzers
(Clauss Method). Freeze-dried human thrombin (~80 NIH units/mL)
with heparin inhibitor and calcium.
00611
Determination of Thrombin Time by STA® analyzers.
Freeze-dried human thrombin (1.5 NIH units/mL) with calcium.
00669
Determination of Thrombin Time by STA® analyzers.
Freeze-dried human thrombin (1.5 NIH units/mL) with calcium.
00614
Determination of Reptilase® Time. Extracted venom
of Bothrops atrox, ~20 BU (Batroxobin unit) per vial.
* ISI values for PT reagents are approximations. Actual ISI values are assigned for each lot of PT reagent.
10
Factor Assays
Section 4
CAT. NO.
CONTENTS
00722
STA -Deficient XII
6 x 1 mL vials
STA®-Deficient XI
6 x 1 mL vials
STA®-Deficient IX
6 x 1 mL vials
STA®-Deficient VIII
6 x 1 mL vials
STA®-Deficient X
6 x 1 mL vials
STA®-Deficient VII
6 x 1 mL vials
STA®-Deficient V
6 x 1 mL vials
STA®-Deficient II
6 x 1 mL vials
Asserachrom® IX:Ag
3 x 2 Coated Strips
3 x 8 mL vials of Anti-IX:Ag-Peroxidase
3 x 8 mL vials of TMB
3 x 50 mL bottles of Dilution Buffer
1 x 50 mL bottle of Washing Solution
3 x 0.5 mL vials of F. IX:Ag Calibrator
3 x 0.5 mL vials of F. IX:Ag Control
1 Plate Frame; 1 Plate Cover
®
Substrate plasma for Factor XII assay by STA® analyzers.
Freeze-dried human plasma lacking Factor XII.
00723
Substrate plasma for Factor XI assay by STA® analyzers.
Freeze-dried human plasma lacking Factor XI.
00724
Substrate plasma for Factor IX assay by STA® analyzers.
Freeze-dried human plasma from which Factor IX has been removed by
selective immuno-adsorption.
00725
Substrate plasma for Factor VIII assay by STA® analyzers.
Freeze-dried human plasma from which Factor VIII has been removed by
00738
Substrate plasma for Factor X assay by STA® analyzers.
Freeze-dried human plasma from which Factor X has been removed by
00743
Substrate plasma for Factor VII assay by STA® analyzers.
Freeze-dried human plasma from which Factor VII has been removed by
00744
Substrate plasma for Factor V assay by STA® analyzers.
Freeze-dried human plasma, artificially depleted of Factor V.
00745
Substrate plasma for Factor II assay by STA® analyzers.
Freeze-dried human serum and absorbed bovine plasma,
the latter providing Factor V and fibrinogen to the test system.
00943
Enzyme immunoassay of Factor IX Antigen by ELISA method, 96 tests.
11
Section 5
CAT. NO.
Anticoagulants
CONTENTS
Heparin Anti-Xa Chromogenic Assays
00311US
STA®-Liquid Anti-Xa 4
6 x 4 mL vials of Reagent 1 (Substrate)
6 x 4 mL vials of Reagent 2 (F.Xa)
STA®-Liquid Anti-Xa 8
6 x 8 mL vials of Reagent 1 (Substrate)
6 x 8 mL vials of Reagent 2 (F.Xa)
Chromogenic assay for the quantitative determination of unfractionated
(UFH) and low molecular weight heparins (LMWH) in plasma by
measuring anti-Xa activity on antithrombin in a competitive assay by
STA® analyzers.
00322US
Chromogenic assay for the quantitative determination of unfractionated
(UFH) and low molecular weight heparins (LMWH) in plasma by
measuring anti-Xa activity on antithrombin in a competitive assay by
STA® analyzers.
00906
4 x 2 mL vials of AT III
Chromogenic assay of unfractionated and low molecular weight heparins. 2 x 15 mL vials of Buffer
4 x 4 mL vials of F. Xa
Lyophilized chromogenic substrate CBS 31.39, purified bovine AT III,
4 x 4 mL vials of Substrate
purified bovine Factor Xa, Tris buffer.
Stachrom® Heparin
Heparin Induced Thrombocytopenia (HIT)
00615
Asserachrom® HPIA (ELISA)
Determination of anti-heparin - PF4 antibodies by ELISA method,
48 tests.
Section 6
CAT. NO.
3 x 2 Coated Strips
6 x 2 mL vials of Anti-lgG,A,M-Peroxidase
3 x 1 mL vials of HPIA Reference
3 x 1 mL vials of Control 1
Thrombophilia
CONTENTS
STA®-Liatest® Free Protein S
6 x 6 mL vials of Latex
6 x 5 mL vials of Buffer
Liatest® AT III
lnhibitors
00516
lmmuno-turbidimetric assay for Free Protein S Antigen by STA®
analyzers. Suspension of microparticles coated with
monoclonal antibodies to Free Protein S.
00568
lmmuno-turbidimetric assay for Antithrombin Antigen. Suspension of
microlatex particles coated with rabbit anti-human AT antibodies.
00570
12
lmmuno-turbidimetric assay for Total Protein S Antigen. Suspension of
microlatex partlcles coated with rabbit anti-human total protein S antibodies.
Liatest® Protein S
Thrombophilia (continued)
Section 6
CAT. NO.
CONTENTS
00596
STA -Stachrom AT III
4 x 3 mL vials of Thrombin
4 x 3 mL vials of Thrombin Solvent
STA®-Stachrom® Protein C
6 x 3 mL vials of PC-Actlvator
STA®-Staclot® Protein S
2 x 1 mL vials of Protein S Deficient Plasma
2 x 1 mL vials of PCa
2 x 1 mL vials of F.Va
STA®-Staclot® Protein C
3 x 1 mL vials of Protein C Deficient Plasma
3 x 1 mL vials of PC-Activator
Asserachrom® Protein C
3 x 2 Coated Strips
3 x 8 mL vials of Anti-Protein C-Peroxidase
1 x 50 mL bottles of Washing Solution
3 x 0.5 mL bottles of Protein C Calibrator
3 x 0.5 mL bottles of Protein C Control
Asserachrom® Total Protein S
3 x 2 Coated Strips
3 x 2 mL vials of Anti-Total PS-Peroxidase
3 x 0.5 mL bottles of Total Protein S Calibrator
3 x 0.5 mL bottles of Total Protein S Control
Asserachrom® Free Protein S
3 x 2 Coated Strips
3 x 2 mL vials of Anti-Free PS-Peroxidase
3 x 0.5 mL bottles of Free Protein S Calibrator
3 x 0.5 mL bottles of Free Protein S Control
®
®
Chromogenic assay of Antithrombin activity by STA® analyzers. Bovine
thrombin ~ 11.3 nKat/mL, freeze-dried.
00671
Chromogenic assay for the quantitative determination of functional
Protein C by STA® analyzers. Highly purified extract of Agkistrodon c.
contortrix venom for specific activation of Protein C with chromogenic
substrate CBS 42.46 of ~15 μmoles/vial.
00746
Clotting assay for the quantitative measurement of the functional
Protein S level based on the principal of Factor Va inhibition by STA®
analyzers. Lyophilized human plasma, human activated Protein C;
bovine Va; free of Protein S.
00747
Clotting assay of Protein C activity of STA® analyzers.
Lyophilized human plasma free of Protein C; highly purified extract of
Agkistrodon c. contortrix venom for specific activation of Protein C.
Freeze-dried with an activator selected specially for Protein C assay.
00944
Enzyme lmmunoassay for Protein C Antigen
by ELISA method, 96 tests.
00945
Enzyme immunoassay for Total Protein S Antigen
by ELISA Method, 96 tests.
00946
Enzyme immunoassay for Free Protein S Antigen
by ELISA Method, 96 tests.
13
Section 6
CAT. NO.
Thrombophilia (continued)
CONTENTS
00339
STA®-Staclot® DRVV Screen 2
12 x 2 mL vials
STA®-Staclot® DRVV Screen 5
12 x 5 mL vials
STA®-Staclot® DRVV Confirm
12 x 2 mL vials
Staclot® LA
2 x 0.25 mL vials of Phospholipids
4 x 0.5 mL vials of Normal Plasma
2 x 1 mL vials of PTT-LS
2 x 1.5 mL vials of Solvent
Staclot® LA 20
Detection of Lupus Anticoagulants.
Freeze-dried hexagonal phase phosphatidylethanolamine, normal
human plasma with heparin inhibitor, PTT-LS reagent of cephalin and
particulate activator (silica), 20 tests.
2 x 0.5 mL vials of Phospholipids
4 x 0.5 mL vials of Normal Plasma
2 x 2 mL vials of PTT-LS
2 x 2.5 mL vials of Solvent
PTT-LA (LA Screen)
6 x 2 mL vials
Pool Norm
12 x 1 mL vials
Detection of Lupus Anticoagulants by the diluted Russell’s viper venom
test by STA® analyzers.
Russell’s viper venom, phospholipids (low concentration), calcium and
heparin inhibitor, freeze-dried.
00333
Russell’s viper venom, phospholipids (low concentration), calcium and
00334
Russell’s viper venom, phospholipids (high concentration), calcium and
00600
Detection of Lupus Anticoagulants.
Freeze-dried hexagonal phase phosphatidylethanolamine, normal
human plasma with heparin inhibitor, PTT-LS reagent of cephalin and
particulate activator (silica), 10 tests.
00594
00599
Lupus Anticoagulant sensitive APTT reagent.
Cephalin reagent with particulate activator (silica), freeze-dried.
01139
For use as a normal control for the activated partial thromboplastin time
(APTT) and dilute Russell’s viper venom time (dRVVT) assays.
A lyophilized pool, consisting of at least 20 citrated normal human
plasmas.
14
Fibrin Formation & Degradation
Section 7
CAT. NO.
CONTENTS
00515
STA -Liatest D-Di
Asserachrom® D-Di
3 x 2 Coated Strips
3 x 8 mL vials of Anti-D-Peroxidase
3 x 0.5 mL vials of D-Di Calibrator
3 x 0.5 mL vials of D-Di Control
D-Di Test®
1 x 1.3 mL vial of Latex
1 x 20 mL bottle of Buffer
1 x 1 mL vial of Negative Control
1 x 1 mL vial of Positive Control
10 - Test Cards; Mixing Rods
®
®
Immuno-turbidimetric assay of D-dimer by STA® analyzers. Microlatex
particles coated with two different mouse monoclonal anti-human
D-dimer antibodies.
00947
Enzyme immunoassay of D-dimer by ELISA method, 96 tests.
00454
Latex agglutination slide test for the qualitative and semi-quantitative
determination of D-dimer in plasma, 60 tests.
00550
Test cards for D-Di Test kit
10 test cards
00540
1 x 1.3 mL vial of latex
FDP Plasma
Qualitative and semi-quantitative determination of fibrinogen degradation 1 x 1.3 mLvial of negative control
1 x 1.3 mL vial of positive control
products (FDP) in plasma by latex agglutination.
1 x 1.3 mL vial of buffer
10 test cards mixing rods
00541
FDP Plasma (Latex)
12 x 1.3 mL vials of x 20 latex
00551
FDP Plasma (Buffer)
12 vials of buffer
00548
F.S./FDP Plasma Test Cards
10 test cards
For use with catalog #00540 and #00887.
8 x 0.2 mL vials of F.S. Test Unit Reagent
Stat detection of soluble fibrin monomer complexes by hemagglutination, 8 x 0.2 mL vials of Positive Control
8 x 0.2 mL vials of Negative Control
32 tests.
10 - Test Cards
00887
F.S. Test Unit
00857
F.S. Test
4 x 0.5 mL vials of F.S. Test Reagent
Batch detection of soluble fibrin monomer complexes by hemagglutination, 4 x 0.5 mL vials of Positive Control
4 x 0.5 mL vials of Negative Control
40 tests.
15
Fibrinolysis
Section 8
CAT. NO.
CONTENTS
00658
STA®-Stachrom® Plasminogen
6 x 3 mL vials of Streptokinase
STA®-Stachrom® Antiplasmin
4 x 2 mL vials of Plasmin
4 x 2 mL vials of Plasmin Solvent
Asserachrom® tPA
3 x 2 Coated Strips
3 x 8 mL vials of Anti-tPA-Peroxidase
3 x 50 mL bottle of Dilution Buffer
3 x 0.5 mL vials of tPA Calibrator
3 x 0.5 mL vials of tPA Control
1 Plate Frame; 3 Plate Covers
Chromogenic assay of plasminogen activity by STA® analyzers.
00659
Chromogenic assay of antiplasmin activity by STA® analyzers.
00948
Enzyme immunoassay of tissue plasminogen activator
antigen by ELISA method, 96 tests.
Primary Hemostasis
Section 9
CAT. NO.
CONTENTS
00518
STA -Liatest VWF:Ag
4 x 4 mL vials of Latex Diluent
Asserachrom® VWF:Ag
3 x 2 Coated Strips
3 x 8 mL vials of Anti-VWF-Peroxidase
3 x 0.5 mL vials of VWF:Ag Calibrator
3 x 0.5 mL vials of VWF:Ag Control
Asserachrom® β-TG
3 x 2 Coated Strips
3 x 8 mL vials of Anti- β-TG-Peroxidase
3 x 0.5 mL vials of β-TG Calibrator
3 x 0.5 mL vials of β-TG Control
Asserachrom® PF4
3 x 2 Coated Strips
3 x 8-mL vials of Anti-PF4-Peroxidase
3 x 0.5 mL vials of PF4 Calibrator
3 x 0.5 mL vials of PF4 Control
®
®
lmmuno-turbidimetric assay of Von Willebrand Factor
(VWF:Ag) Antigen by STA ® analyzers.
Microlatex particles coated with rabbit anti-human VWF antibodies.
00942
Enzyme immunoassay of Von Willebrand Factor Antigen
00950
Enzyme immunoassay for β-Thromboglobulin Antigen
00951
Enzyme immunoassay for Platelet Factor 4
16
Control Plasmas
Section 10
CAT. NO.
CONTENTS
00381
STA®-Quality HNF/UFH
6 x 1 mL vials of STA® Quality HNF/UFH 2
6 x 1 mL vials of STA® Quality HNF/UFH 5
STA®-Coag Control N + ABN
12 x 1 mL vials of STA® Coag Control N
12 x 1 mL vials of STA® Coag Control ABN
STA®-System Control N + P
12 x 1 mL vials of STA® System Control N
12 x 1 mL vials of STA® System Control P
STA®-Liatest® Control N + P
12 x 1 mL vials of STA® Liatest® Control N
12 x 1 mL vials of STA® Liatest® Control P
STA®-HBPM/LMWH Control
6 x 1 mL vials of STA®- Quality HBPM/LMWH Control 3
6 x 1 mL vials of STA®- Quality HBPM/LMWH Control 8
STA®-Heparin Control
6 x 1 mL vials of STA® Heparin Control 2
6 x 1 mL vials of STA® Heparin Control 5
STA®-Quality HBPM/LMWH
6 x 1mL vials of STA® Quality HBPM/LMWH Control 8
6 x 1mL vials of STA® Quality HBPM/LMWH Control14
STA®-Control LA 1 + 2
3 x 1 mL vials of STA® Control LA 1
3 x 1 mL vials of STA® Control LA 2
STA®-Coag Control N + ABN Plus
12 x 2 mL vials of STA® - Coag Control N Plus
12 x 2 mL vials of STA® - Coag Control ABN Plus
Control plasma for assay of unfractionated heparin (UFH)
using the STA ® Liquid Anti-Xa method on STA® analyzers.
00676
Multi-constituent normal and abnormal plasma controls for routine assays
performed on the STA® analyzers.
00678
Multi-constituent normal and abnormal plasma controls for routine and
specialty assays performed on the STA® analyzers.
00526US
Normal and abnormal control plasmas for immuno-turbidimetric assays
of VWF, D-dimer and Free Protein S on STA® analyzers.
For use with STA® Liatest® VWF:Ag (#00518), STA® Liatest® D-DI
(#00515) and STA® Liatest® Free Protein S (#00516).
00682
Control plasma for assays of low molecular weight heparin (LMWH)
using the Anti-Xa method (Stachrom® Heparin).
00683
Control plasma for assays of unfractionated heparins (UFH) using
the Anti-Xa method (Stachrom® Heparin).
00686
Control plasma for assays of low molecular weight heparins (LMWH)
using the Anti-Xa method on STA® analyzers.
00201
Control plasmas for lupus anticoagulant (LA) detection.
00677
NEW
Normal and abnormal control plasmas for PT INR, APTT, fibrinogen,
thrombin time, and AT (activity) (24-hour stability)
17
Calibrators
Section 11
CAT. NO.
CONTENTS
00348
STA -Multi Hep Calibrator
4 X 1 mL vials of STA® Multi Hep Calibrator 0
STA®-Hepanorm® HBPM/LMWH
4 x 1 mLvials of STA® - Hepanorm® HBPM/LMWH 0
4 x 1 mL vials of STA® - Hepanorm® HBPM/LMWH 4
4 x 1 mL vials of STA® - Hepanorm® HBPM/LMWH 9
STA®-Hepanorm® H
Calibration plasmas for assays of unfractionated heparin (UFH)
4 x 1 mL vials of STA® Hepanorm® H 0
STA®-VWF:Ag Calibrator
6 x 1 mL vials
STA®-Unicalibrator
6 x 1 mL vials
®
Calibration plasmas for both UFH and LMWH using
the STA® Liquid Anti-Xa method on the STA® analyzers.
00681
Calibration plasmas for assays of low molecular weight heparin (LMWH)
00684
00520
Citrated human plasma for the calibration of VWF assays
by the immuno-turbidimetric method on STA® analyzers.
For use with STA® Liatest® VWF:Ag (#00518).
00675
Multi-constituent calibration plasma for functional assays
of coagulation parameters on STA® analyzers.
Section 12
18
Auxiliary Reagents
CAT. NO.
CONTENTS
00279
Polyethylene Glycol (PEG 25%)
6 x 2.5 mL
00360
STA®-Owren-Koller Buffer
24 x 15 mL
00367
STA®-CaCl2 0.025M
24 x 15 mL
00555
Asserachrom® Washing Solution
2 x 50 mL
00973
STA®-Cleaner Solution
6 x 2.5 L
00975US
STA®-Desorb U
24 x 15 mL
Quality & Compliance Solutions
CAT. NO.
Section 13
CONTENTS
EQA (External Quality Assessment)
Qualiris by Stago is a dedicated hemostasis proficiency testing program. Qualiris programs include routine (PT, APTT, Fibrinogen, and Thrombin Time)
hemostasis tests and a wide variety of specialty tests including D-dimer, unfractionated heparin, low molecular weight heparin, factor assays and
thrombophilia assays. Qualiris also offers a diagnostic challenge module for use as competency testing to satisfy continuing education requirements.
Qualiris is an easy to use, web-based system which provides monthly, biannual, and annual reports with quantitative and qualitative statistics. Contact
your sales representative for more information and to set up a custom comparison group.
IQC (Internal Quality Control)
Clarity Check Peer Program by Stago is a comprehensive quality control management program that offers peer comparison with the ability to create
custom peer groups, pre-loaded reagent and QC lot information, 24/7 secure web based program with no need for additional hardware or software, and
flexible report types to review monthly and cumulative data to monitor assay accuracy and precision.
Core Programs
85145
Clarity Check Peer Program
Clarity Check is a comprehensive quality control management program that offers:
• peer comparison with the ability use create custom peer groups
• pre-loaded reagent and QC lot information
• 24/7 secure web based program with no need for additional hardware or software
• flexible report types to review monthly and cumulative data
01044
Qualiris QC Premium Semester 1
12 x 1 mL
Qualiris QC Premium Semester 2
12 x 1 mL
Monthly external quality assessment of PT, APTT, Fibrinogen,
Thrombin Time.
01045
Monthly external quality assessment of PT, APTT, Fibrinogen,
Thrombin Time.
Optional Add-On Programs
85093
Qualiris QC Premium Factors
Monthly external quality assessment of Factors II, V, VII, VIII, IX, X, XI,
XII, & VWF.
85094
Qualiris QC Premium Thrombophilia
Monthly external quality assessment of Antithrombin, Protein C,
Protein S, Plasminogen, Antiplasmin.
01047
Qualiris QC Heparin HBPM / LMWH
6 x 1 mL
Qualiris QC Heparin HNF / UFH
6 x 1 mL
Qualiris QC D-dimer
6 x 1 mL
Qualiris QC Lupus Anticoagulant
3 x 1 mL
Qualiris Diagnostic Challenge
6 x 1 mL
External quality assessment of low molecular weight heparins.
(6 times per year)
01048
External quality assessment of unfractionated heparin.
(6 times per year)
01049
External quality assessment of D-dimer. (6 times per year)
01063
External quality assessment of lupus anticoagulant.
(3 times per year)
01050
Competency assessment with unassayed sample and a Clinical Case
History for CE credit.(3 cases per year)
19
Section 14
Stago Added Value on Request (SAVOR™)
SAVOR™ (Stago Added Value on Request) offers tailored solutions for training, inventory management and other services to enhance
productivity and efficiency. For additional details related to logistics and pricing contact your Stago Account Manager.
Basic Operator Training
Training at our Parsippany, New Jersey facility is included with each new instrument purchased. Price includes transportation, hotel, meals and
training materials for in-house train-the-trainer implementation.
Following the completion of this course, participants will be able to:
• Recognize analyzer hardware
• Prepare and load consumables/reagents
• Complete practice runs included in the training materials
• Understand the software
• Perform user maintenance functions on the analyzer
20
CAT. NO.
INSTRUMENTS
08416
STA Compact Max® & STA Compact®
08417
STA R Max® & STA-R Evolution®
Stago Added Value on Request (SAVOR™) cont.
Section 14
Reagent Application Technical Support
08427
On-Site Technical Assistance
The Stago Technical Support Specialist will assist with adding a test parameter to a Stago instrument. Assistance could include test set-up,
method validation, running test samples, and data collection and analysis.
Stago Inventory Management
08431
Inventory Management and Shipping
Stago often receives requests for customized inventory management solutions, including sequestering of products that typically would not be
sequestered. A nominal fee is to charged for this customized solution.
Requirements include:
• Hard copy purchase order with specified quantity
• Shipping schedule including beginning and end dates
Lab Automation
The STA R Max® and STA-R Evolution® can be integrated into a lab automation line. To accomplish the connection, a connection kit and/or
additional accessory items may be required. A Stago automation consultant is available to answer questions and assure a smooth transition.
CAT. NO.
ACCESSORIES
80182
Kit TLA Type 2 Roche (STA-R Evolution®)
80950
Kit TLA Ortho Engen (STA-R Evolution®)
88517
Kit TLA Type 1 Universal (STA-R Evolution®)
88541
Ramp and Adjustment (STA R Max® and STA-R Evolution®)
89031
Kit TLA Type 1 Universal (STA R Max®)
89032
Kit TLA Type 1 Ortho Engen (STA R Max®)
89033
Kit TLA Type 2 Roche (STA R Max®)
21
Section 14
Method Validation
Standard Service: Accurate method validation is key to maintaining standardization and quality of results. In depth training and tools are
provided during the new instrument training program. Standard method validation services include telephone support by your Stago Technical
Support Specialist for review of protocols,to answer questions, and to provide final data review.
SAVOR Method Validation Service: For customers who would prefer to have a Stago Technical Support Specialist on-site to coordinate and
perform method validation, the Technical Support Specialist will run the tests, collect data, perform data analysis and provide an electronic data
presentation.
CAT. NO.
DAYS OF ON-SITE SUPPORT
SERVICE DESCRIPTION
08428
3
Routine Assays: PT, APTT, Fib, TT, D-dimer
08429
4
Routine + Specialty Assays
CAT. NO.
DESCRIPTION
85080
Method Validation Binder: For customers without access to a network enabled computer,
Stago provides the convenience of a paper report.
Lot Conversion
Lot Conversion/Simple Method Validation (eg. a single test parameter)
Lot Conversion: For customers who would prefer to have a Stago Technical Support Specialist on-site to perform a lot conversion,
the Technical Support Specialist will run the tests, collect data, perform data analysis and provide an electronic data presentation.
Method Validation: A Stago Technical Support Specialist will be on-site for one full day to perform method validation studies. Prior to arrival
the Technical Support Specialist will work with the lead coagulation technologist/key operator to develop the plan for sample requirements
and time management. The Technical Support Specialist will schedule a time to be present to run samples, generate data and complete the process.
CAT. NO.
DAYS OF ON-SITE SUPPORT
SERVICE DESCRIPTION
08430
1
Routine Assay Lot Conversion
Lot Conversion Analysis
A Stago Technical Support Specialist will receive data generated by the lab via email, fax or other locally acceptable means of sharing data. The
Technical Support Specialist will load the data into the appropriate template, review data for outliers, and provide a report back to the customer.
22
CAT. NO.
SERVICE DESCRIPTION
08434
TSS Assistance: Lot Conversion Analysis
Section 14
Preventive Maintenance on Demand
Preventive Maintenance on Demand is designed for customers who have a backup instrument that does not include a service contract.
The Stago Field Service Group will perform a preventative maintenance program which includes decontamination of the instrument, general
cleaning, instrument calibration, replacement of filters, and a biological test for precision. Price includes travel, parts and labor.
CAT. NO.
INSTRUMENT
SERVICE DESCRIPTION
85075
STA Compact Max® & STA Compact®
Preventative Maintenance
85076
STA R Max® & STA-R Evolution®
Preventative Maintenance
Instrument Decommission
A Stago Field Service Engineer will decontaminate your retired coagulation instrument and remove the hard drive in compliance with local regulatory
and HIPAA requirements.
CAT. NO.
SERVICE DESCRIPTION
85077
Decommission
85078
Decommission and return instrument to Stago for disposal
85079
Special visit to perform decommission procedure
23
Section 15
Thrombin Generation Research Products
(Research Use only, not for use in diagnostic procedures)
CAT. NO.
CONTENTS
Calibrated Automated Thrombogram®
Thermo Electron Fluoroskan Ascent Analyzer
Computer
Thrombinoscope Software
Operator’s reference manual
Dongle
Filters: 1 - 390 nm, 1- 460 nm
Thrombin Calibrator
20 x 16 tests
PPP Reagent
20 x 16 tests
PPP Reagent LOW
20 x 16 tests
PPP Reagent HIGH
20 x 16 tests
PRP Reagent
20 x 16 tests
FluCa Kit
10 x 16 tests
MP Reagent
20 x 16 tests
Instrument
86186
The Calibrated Automated Thrombogram® (CAT) measures
the concentration of thrombin generated over time in clotting plasma
using either platelet poor or platelet rich plasma.
The CAT corrects for substrate consumption, the inner filter effect and
color differences between plasmas by running a calibrator with every patient
sample. The CAT provides a description of hyper- as well as hypo-activity
of the clotting system.
Reagents
86192
Corrects for substrate consumption, the inner filter effect and color
differences between plasmas, which is necessary for use in parallel
with each sample.
86193
Used with platelet poor plasma for general applications using the
CAT System.
86194
Used with platelet poor plasma and has a high sensitivity to Factors VIII,
IX and XI. This reagent increases sensitivity in hemophiliac plasma.
86195
Used with platelet poor plasma when thrombin generation is strongly
inhibited. This reagent increases sensitivity in plasmas containing
anticoagulants such as heparin.
86196
Used with platelet-rich plasma for thrombin generation measurements.
PRP-Reagent can also be used in platelet-poor plasma to determine the
presence of phospholipids and to examine the activity of phospholipid
microparticles.
86197
Specific fluorogenic substrate and buffer suitable for thrombin generation.
86222
Used with platelet-free plasma and is specifically sensitive to circulating
Tissue Factor present on the surface of procoagulant microparticles.
Disposables & Accessories
86175
Immulon Round Bottom plate, 2HB
50/box
86176
Dispensing Tip
1 tip
Thrombinoscope Package
1 Thrombinoscope software and 1 dongle
1 replacement tip for use with dispenser tip assembly of Calibrated
Automated Thrombogram (CAT) instrument.
86191
Trombinoscope Software and dongle for running thrombin generation
experiments via the Calibrated Thrombogram (CAT) platform.
The Thrombinoscope Package can be purchased separately if the user
already has a Fluoroskan Ascent® FL or Ascent® instrument along with
a desktop computer with a RS232 serial port connection available.
24
Ecarin Chromogenic Assay (ECA) Products
Section 16
CAT. NO.
01108
STA -ECA II
01109
STA®-Dabigatran Calibrator
2 x 3.5 mL Prothrombin Reagent
Quantitative determination of dabigatran in plasma samples by the Ecarin 2 x 2 mL Substrate
2 x 2 mL Ecarin Reagent
Chromogenic Assay (ECA) method.
Calibration plasmas for dabigatran measurement using Ecarin
Chromogenic Assay method.
01110
CONTENTS
®
2 x 1 mL vials of Calibrator 0
3 x 1 mL Vials of Control 1
Control plasmas for dabigatran measurement using Ecarin Chromogenic 3 x 1 mL Vials of Control 2
Assay method.
STA®-Dabigatran Control
25
Flow Cytometry Research Products
Section 17
CAT. NO.
CONTENTS
Flow Cytometry research kits from BioCytex
00111
Platelet Gp Receptors
5 tests
The PLT Gp/Receptors kit allows precise quantitation of GpIIb, GpIb and GMP140 glycoproteins on platelet surfaces in the
resting state and after TRAP (Thrombin Receptor Agonist Peptide) activation for detection of constitutive thrombopathies,
including Glanzmann Thrombasthenia, Bernard Soulier syndrome, Fechtner syndrome, X-linked thrombocytopenia, and Gray
platelet syndrome.
00112
Platelet Gpllb/llla Occupancy
10 tests
Single color flow cytometric analysis of the GpIIb/IIIa glycoprotein receptor for testing of occupancy by various anti-GpIIb/IIIa
drugs including abciximab (Reopro®), eptifibatide (Integrilin®), or tirofiban (Aggrastat®).
00418
Platelet Gp Screen
10 tests
Single color flow cytometric analysis of the platelet glycoproteins GpIIIa, GpIb and GpIa.
00420
Megamix
50 tests
For standardizing microparticle setup within a given analysis region (0.5-1 μm) and providing setting stability.
00449
Platelet VASP/P2Y12
10 tests
For responsive testing of specific platelet ADP receptor (P2Y12) antagonists, including clopidogrel (Plavix®), prasugrel (Effient®),
and ticagrelor (Brilinta®).
00452
Platelet PAlg Kit
10 tests
For dual color flow cytometric analysis of Platelet Associated Immunoglobulins (PAIg).
00457
Platelet Calibrator
5 curves
Calibration kit for the measurement of platelet glycoprotein expression level or any other human platelet surface molecules.
01000
Cellquant PNH
12 tests
For analysis of deficiencies of CD55 and CD59 on the granulocyte surface for the purpose of analyzing samples from patients
suspected of Paroxysmal Nocturnal Haemoglobinuria (PNH).
01001
Cellquant Calibrator
5 curves
Calibration kit for the measurement of human leukocyte surface antigen expression level by multiple color analysis.
01003
Redquant PNH
12 tests
For analysis of deficiencies of CD55 and CD59 on the red blood cell surface for the purpose of analyzing samples from patients
suspected of Paroxysmal Nocturnal Haemoglobinuria (PNH).
01077
Megamix-Plus FSC
50 tests
For standardizing microparticle setup within a given analysis region (0.3-1 µm) and providing setting stability. Designed for use with
newer generation forward scatter (FSC)-optimized flow cytometer models such as the Gallios® or Navios® from Beckman Coulter.
01078
Megamix-Plus SSC
50 tests
For standardizing microparticle setup within a given analysis region (0.3-1 µm) and providing setting stability. Designed for use
with newer generation forward scatter (SSC)-optimized flow cytometer models from Becton Dickinson.
27
Section 17
Flow Cytometry Research Products (continued)
CAT. NO.
CONTENTS
Monoclonal antibodies for flow cytometry from BioCytex
28
01005
Fibrinogen, clone 9F9, FITC
100 tests
01006
CD146, clone COM3D9, purified
100 tests
01007
CD146, clone COM2F6, purified
100 tests
01008
CD146, clone COM5G6, purified
100 tests
01009
CD146, clone COM7A4, Biotin
100 tests
01010
CD146, clone COM7A4, FITC
100 tests
01011
CD146, clone COM7A4, purified
100 tests
01012
CD146, clone S-Endo 1, Biotin
100 tests
01013
CD146, clone S-Endo 1, FITC
100 tests
01014
CD146, clone S-Endo 1, purified
100 tests
01015
CD146, clone S-Endo 1, PE
100 tests
01016
CD61, clone 4F8, FITC
100 tests
01017
CD61, clone 4F8, purified
100 µg
01018
Ctl. neg. lgG1 - FITC (2DNP2H11)
100 tests
01019
Ctl. neg. lgG1 purified (2DNP2H11)
100 µg
01020
Ctl. neg. lgG1 - PE (2DNP2H11)
100 tests
01021
CD62P, clone LYP20, FITC
100 tests
01022
CD62P, clone LYP20, purified
100 µg
01023
CD62P, clone LYP20, PE
100 tests
01024
CD41, clone PL2-49, FITC
100 tests
01025
CD41, clone PL2-49, purified
100 µg
01026
CD41, clone PL2-49, PE
100 tests
01027
CD42b, clone ALMA 19, FITC
100 tests
01028
CD42b, clone ALMA 19, purified
100 µg
01029
CD42b, clone ALMA 19, PE
100 tests
01030
CD36, clone 10.5, FITC
100 tests
01031
CD36, clone 10.5, purified
100 µg
Flow Cytometry Research Products (continued)
Section 17
CAT. NO.
CONTENTS
Monoclonal antibodies for flow cytometry from BioCytex
01032
CD36, clone 10.5, PE
100 tests
01033
CD32, clone 2B2, purified
100 µg
01034
Ctl. neg. lgG2b-FITC (2DNP14G5)
100 tests
01035
Ctl. neg. lgG2b purified (2DNP14G5)
100 µg
01036
Ctl. neg. lgG2b PE (2DNP14G5)
100 tests
01037
Ctl. neg. lgG2a-FITC (2DNP16C12)
100 tests
01038
Ctl. neg. lgG2a purified (2DNP16C12)
100 µg
01039
Ctl. neg. lgG2a - PE (2DNP16C12)
100 tests
01040
CD61, clone LYP18, FITC
100 tests
01041
CD61, clone LYP18, purified
100 µg
01042
CD61, clone LYP18, PE 100 tests
100 µg
01083
Anti-human GPVI, purified
100 µg
01084
Anti-human GPVI, PE
100 tests
29
Section 18
Research Kits
CAT. NO.
00261
Asserachrom® Total TFPI
00262
Asserachrom® Free TFPI
00264
Asserachrom® sEPCR
3 x 2 Coated Strips
3 x 8 mL vials of Anti-sEPCR-Peroxidase
3 x 0.5 mL vials of sEPCR Calibrator
3 x 0.5 mL vials of sEPCR Control
Asserachrom® Anti-Prothrombin IgG,M
3 x 2 Coated Strips
3 x 4 mL vials of Anti-IgG-Peroxidase
3 x 4 mL vials of Anti-IgM-Peroxidase
3 x 2 mL vials of Anti-Prothrombin IgG,M Calibrator
Asserachrom® Soluble GPV
3 x 2 Coated Strips
3 x 8 mL vials of Anti-sGPV-Peroxidase
3 x 50mL bottles of Dilution Buffer
3 x 0.5 mL vials of sGPV Calibrator
3 x 0.5 mL vials of sGPV Control
Asserachrom® VIII:Ag
3 x 2 Coated Strips
3 x 8 mL vials of Anti- F.VIII:Ag-Peroxidase
3 x 50mL bottles of Dilution Buffer
3 x 0.5 mL vials of F. VIII:Ag Calibrator
3 x 0.5 mL vials of F. VIII:Ag Control
1 Plate Frame; 3 Adhesive Films
Staclot® VIIa-rTF
2 x 1 mL vials of F. VII Deficient Plasma
2 x 1 mL vials of rsTF-Phospholipids
2 x 0.5 mL vials of F. VIIa Calibrator
2 x 0.5 mL vials of F. VIIa Control 1
2 x 0.5 mL vials of F. VIIa Control 2
3 x 2 Coated Strips
Quantitative determination of total Tissue Factor Pathway Inhibitor (TFPI) 3 x 2 mL vials of Anti-Total TFPI-Peroxidase
6 tablets of Ortho-Phenylenediamine
3 x 0.5 mL vials of Total TFPI Calibrator
3 x 0.5 mL vials of Total TFPI Control
6 tablets of Urea Peroxide
3 x 2 Coated Strips
Quantitative determination of free Tissue Factor Pathway Inhibitor (TFPI) 3 x 2 mL vials of Anti-Free TFPI-Peroxidase
6 tablets of Ortho-Phenylenediamine
6 tablets of Urea Peroxide
2 x 50 mL bottles Dilution Buffer
3 x 0.5 mL vials of Free TFPI Calibrator
3 x 0.5 mL vials of Free TFPI Control
Quantitative determination of soluble Endothelial Protein C Receptor by
ELISA method, 96 tests.
00265
Semi-quantitative determination of anti-prothrombin antibodies of IgG
and/or IgM class by ELISA method, 96 tests.
00276
Quantitative determination of soluble Glycoprotein V
00280
Quantitative determination of Factor VIII Antigen
00281
Clotting assay of activated Factor VII, 20 tests.
30
CONTENTS
Research Kits (continued)
Section 18
CAT. NO.
CONTENTS
00346
STA -Stachrom TAFI
2 x 2 mL vials of TAFI Activator
4 x 4 mL vials of Carboxypeptidase A
2 x 1 mL vials of TAFI Calibator
2 x 1 mL vials of TAFI Control
STA®-Procoag-PPL
3 x 1 mL vials of P-PPL Depleted plasma
3 x 4 mL vials of F.Xa, ~0.040 IU/vial
3 x 1 mL vials of P-PPL Control N
3 x 1 mL vials of P-PPL Control P
Asserachrom® Vlla-AT
3 x 2 Coated Strips
3 x 8 mL vials of Anti-AT-Peroxidase
3 x 50 mL Bottles of Sample Buffer
3 x 15 mL vials of Dilution Buffer
3 x 0.5 mL vials of Vlla-AT Calibrator
3 x 0.5 mL vials of Vlla-AT Control
1 Plate Frame; 1 Adhesive Film
STA®-Liatest® FM
90 tests
STA®-FM Calibrator
A set of calibrator plasmas intended for calibration of
the immunoturbidimetric method. To be used with 00543US.
2 x 1 mL vials of calibrator 1
STA®-FM Control
6 x 1 mL vials of control 1
6 x 1 mL vials of control 2
Liatest® C4b-BP
Asserachrom® TAFIa/TAFIai
3 x 2 Coated Strips
3 x 8 mL vials of Anti-TAFIa/TAFIai-Peroxidase
3 x 50 mL Bottles of Dilution Buffer
1 x 50 mL Bottle of Washing Solution
3 x 0.5 mL vials of TAFIa/TAFIai Calibrator
3 x 0.5 mL vials of TAFIa/TAFIai Control
STA®-Rivaroxaban Calibrator
Calibration plasmas for rivaroxaban measurement
using chromogenic anti-Xa Method.
STA®-Rivaroxaban Control
Stachrom® Heparin Cofactor II
6 x 2 mL vials of Thrombin
1 x 15 mL bottle of Buffer
®
®
Quantitative determination of thrombin activable fibrinolysis
inhibitor activity, Chromogenic Assay, 60 tests.
00429
Clot-based assay for the detection of procoagulant phospholipids by
STA® analyzer, 60 tests.
00491
Quantitative determination of the FVlla-AT complex
00543US
Immuno-turbidimetric assay of Fibrin Monomer by STA® analyzers.
Microlatex particles coated with two different mouse monoclonal
anti-human fibrin monomer antibodies, 90 tests.
00544US
00545US
Two plasmas intended for the quality control of
the immunoturbidimetric method. To be used with 00543US.
00581
Quantitative determination of C4b-BP
by Immuno-turbidimetric measurement, 60 tests.
00616
Quantitative determination of TAFIa/TAFIai
00704US
00706US
Control plasmas for rivaroxaban measurement
using chromogenic anti-Xa Method.
00851
Chromogenic assay of heparin cofactor II activity, 60 tests.
31
Section 18
Research Kits (continued)
CAT. NO.
CONTENTS
00853
Stachrom PAI
2 x 2 mL vials of Urokinase
2 x 2 mL vials of Plasminogen
2 x 0.5 mL vials of PAI Calibrator 1
Asserachrom® PAI-1
3 x 2 Coated Strips
3 x 8 mL vials of Anti-PAI-1-Peroxidase
3 x 2 mL vials of PAI-1 Calibrator
3 x 2 mL vials of PAI-1 Control
Asserachrom® VII:Ag
3 x 2 Coated Strips
3 x 8 mL vials of Anti-VII:Ag Peroxidase
3 x 50 mL vials Dilution Buffer
1 x 50 mL vial Washing Solution
3 x 0.5 mL vials of F. VII:Ag Calibrator
3 x 0.5 mL vials of F. VII:Ag Control
1 Plate Frame
1 Plate Cover
Asserachrom® X:Ag
3 x 2 Coated Strips
3 x 8 mL vials of Anti-X:Ag Peroxidase
3 x 50 mL vials Dilution Buffer
1 x 50 mL vial Washing Solution
3 x 0.5 mL vials of F. X:Ag Calibrator
3 x 0.5 mL vials of F. X:Ag Control
1 Plate Frame
1 Plate Cover
Cy-Quant CD146
3 x 2 Coated Strips
3 vials of Calibrator
1 vial of Stop Solution
1 vial of TMB
1 vial of Washing solution
1 vial of Dilution buffer
1 vial of Anti CD146-peroxidase
1 vial of Control plasma
1 Plate Frame
STA®-Apixaban Control
STA®-Apixaban Calibrator
Asserachrom® VWF: FVIIIB
3 x 2 Coated Strips
3 x 8 mL vials of recombinant FVIII
3 x 8 mL vials of Anti-FVIII-Peroxidase
3 x 15 mL vials of Dilution Buffer
3 x 20 mL vials of Reconstitution Buffer
3 x 2 mL vials of vWF:FVIIIB Calibrator
3 x 2 mL vials of vWF:FVIIIB Control
®
Chromogenic assay of plasminogen activator inhibitor activity, 20 tests.
00949US
Quantitative determination of plasminogen activator inhibitor-1
Antigen (PAI-1) by ELISA method, 96 tests.
00955
Quantitative determination of Factor VII:Ag
00956
Quantitative determination of Factor X:Ag
01004
For the determination of soluble CD146 (sCD146, S-ENDO 1, MUC 18,
melanoma cell adhesion molecule) in plasma and serum, by ELISA
method, 96 tests.
01111
Control plasmas for apixaban measurement using chromogenic
anti-Xa Method.
01112
Calibration plasmas for apixaban mesurement chromogenic
anti-Xa Method.
01138
Kit for the quantitative determination of the capacity of von Willebrand
factor to bind to factor VIII (VWF:FVIIIB) by enzyme-linked
immunosorbent assay (ELISA), 96 tests.
32
Research Components
Section 19
CAT. NO.
CONTENTS
Purified Proteins
a
00461
Purified VWF
100 µg
00462
Purified Factor X
20 Plasma Equivalent Units (PEU), approx 200 μg
00463
Purified Heparin Cofactor II
00519
Purified Fibrinogen
8 mg
00557
Purified Prothrombin
00828
Purified APC
10 μg
00888
Purified AT III
150 μg
00896
Purified Thrombin
1000 NIH Units
00912
Purified Factor Xa
10 μg
Chromogenic Substratesb
00811
CBS 31.39 (Substrate for Factor Xa)
1 vial, 7.5 μMoles
00873
CBS 34.47 (Substrate for Thrombin)
1 vial, 7.5 μMoles
Venoms and Inhibitorsb
00823
Ecarin
1 vial, 50 Ecarin Units (EU)
00830
r-Hirudin
1 vial, 2,000 r-Hirudin Antithrombin Units (ATU)
b All chromogenic substrates, venoms and inhibitors are freeze-dried.
a Purified proteins are freeze-dried and are from human sources.
33
Abbreviations
ABBREVIATION NAME
34 ABBREVIATION NAME
α2-AP
Alpha-2-Antiplasmin
GPO
Group Purchasing Organization
ACA
Anticardiolipin Antibodies
GPV
Glycoprotein V
APA
Antiphospholipid Antibody(ies)
HBPM
Héparines de bas poids moléculaire
(French designation for LMWH)
APC
Activated Protein C
HNF
Heparines non fraccionee
APTT
Activated Partial Thromboplastin Time
LA
AT
Antithrombin
LMWH
Low Molecular Weight Heparin
AT:Act
Antithrombin Activity
N+ABN
Normal and Abnormal
AT:Ag
Antithrombin Antigen
N+P
Normal and Pathologic
CaCl2
Calcium Chloride
OPD
Ortho-phenylenediamine
DIC
Disseminated Intravascular Coagulation
PAI 1
Plasminogen Activator Inhibitor 1
DSI
Diagnostica Stago Inc
PC
Protein C
ELISA
Enzyme-Linked Immunosorbent Assay
PF4
Platelet Factor 4
Fib
Fibrinogen
PIVKA
Protein Induced by Vitamin K Antagonists
FDP
Fibrinogen Degradation Products
PNP
Pooled Normal Plasma
FII
Factor II or Prothrombin
PS
Protein S
FOB
Free On Board
PT
Prothrombin Time
FSE
Field Service Engineer
PTT-LA
LA Sensitive APTT
FV
Factor V
TAFI
Thrombin Activable Fibrinolysis Inhibitor
FVII
Factor VII
TFPI
Tissue Factor Pathway Inhibitor
FVIII
Factor VIII
TMB
Tetra Methyl Benzidine
FIX
Factor IX
TSS
Technical Support Specialist
FX
Factor X
TT
Thrombin Time
FXI
Factor XI
UFH
Unfractionated Heparin
FXII
Factor XII
VWD
Von Willebrand Disease
FM
Fibrin Monomer
VWF
Von Willebrand Factor
HEM
tPA
OS
TA
S
P
A
I-1
FDP
D-Dimer
SI
Plasminogen
Plasmin
Fibrin
TM
Fibrinogen
IIa
PC
A
T
IIa
APC PS
II
PS
V
AP
C
A
Va
T
Activated
Platelet
Xa
vWF
X
A
T
IXa VIIIa APC PS
XI
IX
A
T
XIa
VIII
Inhibition pathways
Activation pathways
Coagulation
Fibrinolysis
Xa TFPI VIIa
AT
TF
AT THE HEART OF HEMOSTASIS
AT
PAI-1
APC PS
Xa
TFPI
Terms and Conditions of Sale
FOR REAGENTS, DISPOSABLES & ACCESSORIES
Definitions:
Products: Reagents, Disposables and Accessories as defined
in DSI’s Product catalog in force.
DSI: Diagnostica Stago, Inc., a Delaware corporation with its
principal place of business at Five Century Drive,
Parsippany, NJ 07054, the seller of the Products.
Customer: The person or entity purchasing the Products.
Ordering Information:
Please reference your Customer number when placing all orders.
Orders are accepted by telephone or fax:
Attn: Sales Administration Department
Phone: (800) 222-COAG (2624) Menu option 3
Fax: (973) 426-9460
Monday through Friday: 8:30 am to 5:00 pm
(Eastern Time)
By mail, please refer all orders to:
Attn: Sales Administration Department
330 Waterloo Valley Road
Mount Olive NJ 07828
Application:
These Terms and Conditions of Sale supersede any terms specified in
the purchase order placed by Customer or related correspondence. Any
additions, modifications or deletions made to these Terms and Conditions
of Sale shall be null and void unless approved in writing by DSI. The
failure or delay of DSI to enforce any of these Terms and Conditions of
Sale shall not be deemed to be a waiver by DSI of any such terms. If, at
the time of purchase, Customer is a qualified member of a Group
Purchasing Organization (GPO) having a contract with DSI, conflicting
provisions in these Terms and Conditions of Sale will be interpreted as
per the contract between said GPO and DSI in effect at the time of
purchase.
Payment:
The prices for the Products are those indicated in DSI’s price lists in
effect at the time the order is placed by Customer. A $50.00 minimum
purchase is required. Terms of payment are net 30 days from the date of
DSI’s invoice. Customer shall report any incorrect billing to DSI Sales
Administration within 15 days after the delivery of invoice. Customer
agrees to reimburse DSI on demand for any taxes, fines or penalties
paid by DSI on behalf of Customer. DSI will not bill third party providers
for such payments.
DSI reserves the right, in addition to all other remedies available, at its
sole discretion and without prior notice (i) to suspend deliveries of
Products and to reject any new orders made unless and until payment in
full is made by Customer of all outstanding amounts due to DSI and (ii)
to charge interest on past due amounts at the rate of one and one half
percent (11/2%) per month until paid or the lesser maximum amount
permitted by law.
Delivery:
Products shall be delivered FOB Origin, freight prepaid and added to the
invoice. Delivery of the Products shall be deemed to have occurred at
the earlier of: (i) the date the Products are handed over to the first
carrier, or (ii) in case of an unsuccessful attempt at shipment, two
business days following the sending of notice to Customer stating that
Products are at Customer’s disposal at DSI’s shipping point.
Sequestering:
Reagents to be sequestered (by storing a pre-established quantity of a
single lot of Reagent) are determined by DSI based on Customer’s
sequestering request. Sequestering will require a hard copy Purchase
Order indicating line item quantity and a specified delivery schedule
including beginning and end dates.
First delivery of sequestered Reagents cannot be less than 30 days
from the date of the sequestering request.
Returns:
Customer may not return Reagents ordered in error. Returns will not be
accepted or a credit issued without prior approval and a Return
Authorization Number assigned by a Sales Administration
Representative. Please call (800) 222-COAG Menu option 3.
Two categories of returns will be accepted:
1) Products shipped in error by DSI, and 2) Analyzer parts, disposables,
or accessories, ordered in error by Customer may be returned provided
a Return Authorization number is assigned by a Sales Administration
Representative, the item is returned in the original unopened packaging,
and received undamaged. However, in category 2), Customer will be
charged a 35% restocking fee.
In order to receive replacement Product or credit, the following criteria
must be met: The problem must be reported within 30 working days from
the date stated on the Product invoice;
Returned Product must be in the same condition as it was received; No
returns will be accepted after 30 days from the date on the Product
invoice. Please send all returns indicating the Return Authorization
Number on the outside of the package to:
Return’s Department
Distribution Warehouse
330 Waterloo Valley Road
Mount Olive, NJ 07828
Limited Warranty:
Each of the Products shall be free from defects in material and
workmanship and shall conform to DSI’s specifications as specified in
the package when delivered by DSI.
Subject to DSI’s acceptance of the non-conformity of the Products
delivered, the warranty for defective Products is strictly limited to the
replacement free of charge of the corresponding Products.
EXCEPT TO THE EXTENT OF THE LIMITED WARRANTY SPECIFICALLY
SET FORTH IN THIS ARTICLE, AND NOTWITHSTANDING ANY
PROVISION TO THE CONTRARY CONTAINED HEREIN OR IN ANY
OTHER DOCUMENT, NO WARRANTY OR GUARANTEE, EXPRESS OR
IMPLIED, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR
FITNESS FOR A PARTICULAR PURPOSE OR USE, IS MADE.
In no event shall DSI, its employees or its suppliers be liable for lost
profits or any special common, indirect, incidental, consequential or
exemplary damages, irrespective of whether attributable to contract,
warranty, negligence, strict liability or otherwise.
Governing Law – Venue:
These Terms and Conditions of Sale shall be governed by and
interpreted in accordance with, the laws of the State of New York
applicable to contracts made and wholly performed in New York. All
disputes arising out of or in connection with the order made under these
Terms and Conditions of Sale must be settled by one Arbitrator sitting in
New York City, in accordance with the Commercial Arbitration Rules of
the American Arbitration Association, and judgment upon the award
rendered by the Arbitrator may be entered in any Court having jurisdiction
over the parties.
Main Index
ITEM
PAGE(S)
Anti-human GPVI, PE ......................................................29
Anti-human GPVI purified................................................29
Asserachrom® Anti-Prothrombin IgG, M.........................30
Asserachrom® D-Di.........................................................15
Asserachrom® Free Protein S..........................................13
Asserachrom® Free TFPI.................................................30
Asserachrom® PAl- 1.......................................................32
Asserachrom® Protein C..................................................13
Asserachrom® sEPCR......................................................30
Asserachrom® Soluble GPV.............................................30
Asserachrom® Total Protein S.........................................13
Asserachrom® Total TFPI.................................................30
Asserachrom® tPA...........................................................16
Asserachrom® VII:Ag.......................................................32
Asserachrom® VIII:Ag......................................................30
Asserachrom® VWF:Ag...................................................16
Asserachrom® VWF:FVIIIB..............................................32
Asserachrom® X:Ag.........................................................32
Asserachrom® ß-TG ........................................................16
Asserachrom® HPIA (ELISA)...........................................12
Asserachrom® IX:Ag........................................................ 11
Asserachrom® PF4..........................................................16
Calibrated Automated Thrombogram®............................24
CBS 31.39.......................................................................33
CBS 34.47.......................................................................33
CD146, clone COM2F6, purified....................................28
CD146, clone COM3D9, purified...................................28
CD146, clone COM5G6, purified...................................28
CD146, clone COM7A4, Biotin.......................................28
CD146, clone COM7A4, FITC.........................................28
CD146, clone COM7A4, purified....................................28
CD146, clone S-Endo 1, Biotin.......................................28
CD146, clone S-Endo 1, FITC.........................................28
CD146, clone S-Endo 1, PE............................................28
CD146, clone S-Endo 1, purified....................................28
CD32, clone 2B2, purified..............................................29
CD36, clone 10.5, FITC...................................................28
CD36, clone 10.5, PE......................................................29
CD36, clone 10.5, purified..............................................28
CD41, clone PL2-49, FITC..............................................28
CD41, clone PL2-49, PE.................................................28
CD41, clone PL2-49, purified.........................................28
CD42b, clone ALMA 19, FITC.........................................28
CD42b, clone ALMA 19, PE............................................28
CD42b, clone ALMA 19, purified....................................28
CD61, clone 4F8, FITC....................................................28
CD61, clone LYP18, FITC................................................29
CD61, clone LYP18, PE...................................................29
CD61, clone LYP18, purified...........................................29
CD61, clone 4F8, purified...............................................28
ITEM
PAGE(S)
CD62P, clone LYP20, FITC..............................................28
CD62P, clone LYP20, PE.................................................28
CD62P, clone LYP20, purified.........................................28
Cellquant calibrator..........................................................27
Cellquant PNH.................................................................27
Ctl. Neg. lgG1 - FITC (2DNP2H11)..................................28
Ctl. Neg. lgG1 - PE (2DNP2H11).....................................28
Ctl. Neg. lgG1 - purified (2DNP2H11).............................28
Ctl. Neg. lgG2a PE (2DNP16C12)...................................29
Ctl. Neg. lgG2a purified (2DNP16C12)...........................29
Ctl. Neg. lgG2a - FITC (2DNP16C12)..............................29
Ctl. Neg. lgG2b - FITC (2DNP14G5)...............................29
Ctl. Neg. lgG2b PE (2DNP14G5)....................................29
Ctl. Neg. lgG2b purified (2DNP14G5)............................29
D-Di Test®........................................................................15
Dispensing Tip.................................................................24
Ecarin Chromogenic Assay (ECA)....................................25
External Quality Assessment Program.............................19
F.S. Test............................................................................15
F.S. Test Unit....................................................................15
FDP Plasma......................................................................15
FDP Plasma Buffer...........................................................15
FDP Plasma Latex............................................................15
Fibrinogen, clone 9F9, FITC.............................................28
FluCa Kit...........................................................................24
FS/FDP Plasma Test Cards..............................................15
Halogen Lamp...................................................................7
Internal Quality Control Peer Program ............................19
Immulon Round Bottom plate, 2HB................................24
Liatest® AT III...................................................................12
Liatest® C4b-BP...............................................................31
Liatest® Protein S.............................................................12
Megamix..........................................................................27
Miscellaneous Parts..........................................................8
MP Reagent.....................................................................24
PAlg kit.............................................................................27
Platelet Calibrator.............................................................27
Platelet GP Receptors......................................................27
Platelet Gp Screen...........................................................27
Platelet gpllb/llla Occupancy...........................................27
Platelet VASP/P2Y12.......................................................27
Polyethylene Glycol.........................................................18
Pool Norm.......................................................................14
PPP Reagent....................................................................24
PPP Reagent HIGH..........................................................24
PPP Reagent LOW...........................................................24
PRP Reagent....................................................................24
PTT-LA.............................................................................14
Purified APC....................................................................33
Purified AT III...................................................................33
37
Main Index
ITEM
PAGE(S)
Purified Factor X..............................................................33
Purified Factor Xa.............................................................33
Purified Fibrinogen..........................................................33
Purified Heparin Cofactor II.............................................33
Purified Thrombin............................................................33
Purified VWF....................................................................33
r-Hirudin..........................................................................33
Redquant PNH.................................................................27
STA®-Apixaban Calibrator................................................32
STA®-Apixaban Control....................................................32
STA®-Rivaroxaban Calibrator...........................................31
STA®-Rivaroxaban Control...............................................31
STA®-C.K. Prest 5 ...........................................................10
STA®-CaCl2.......................................................................18
STA®-Cleaner Solution.....................................................18
STA®-Coag Control N + ABN........................................... 17
STA®-Coag Control N + ABN Plus................................... 17
STA Compact Max® Coagulation System..........................4
STA Compact Max® Coag System with Cap Piercing........4
STA®-Control LA 1 + 2..................................................... 17
STA®-Deficient II.............................................................. 11
STA®-Deficient IX............................................................. 11
STA®-Deficient V ............................................................. 11
STA®-Deficient VII ........................................................... 11
STA®-Deficient VIII........................................................... 11
STA®-Deficient X.............................................................. 11
STA®-Deficient XI............................................................. 11
STA®-Deficient XII............................................................ 11
STA®-Desorb U................................................................18
STA®-Fibrinogen 5...........................................................10
Stago Added Value on Request (SAVOR).........................20
STA®-HBPM/LMWH Control........................................... 17
STA®-Hepanorm H...........................................................18
STA®-Hepanorm® HBPM/LMWH....................................18
STA®-Heparin Control...................................................... 17
STA®-Liatest® Control N + P ........................................... 17
STA®-Liatest® D-Di..........................................................15
STA®-Liatest® Free Protein S............................................12
STA®-Liatest® VWF:Ag.....................................................16
STA®-Multi Hep Calibrator...............................................18
STA®-Neoplastine ® CI 5..................................................10
STA®-Neoplastine ® CI Plus 10........................................10
STA®-Neoplastine ® CI Plus 5..........................................10
STA®-Owren-Koller Buffer...............................................18
STA®-Procoag - PPL.........................................................31
STA®-PTT Automate 5.....................................................10
STA®-Quality HBPM/LMWH........................................... 17
STA®-Reptilase.................................................................10
ITEM
PAGE(S)
STA -Liquid Anti-Xa 4......................................................12
STA®-Liquid Anti-Xa 8......................................................12
STA® Satellite® Hemostasis System..................................5
STA®-Stachrom® Antiplasmin..........................................16
STA®-Stachrom® AT III.....................................................13
STA®-Stachrom® Plasminogen.........................................16
STA®-Stachrom® Protein C..............................................13
STA®-Stachrom® TAFI......................................................31
STA®-Staclot® DRVV Confirm..........................................14
STA®-Staclot® DRVV Screen 2.........................................14
STA®-Staclot® DRVV Screen 5.........................................14
STA®-Staclot® Protein C...................................................13
STA®-Staclot® Protein S...................................................13
STA®-System Control N + P............................................. 17
STA®-Thrombin 10...........................................................10
STA®-Thrombin 2.............................................................10
STA®-Unicalibrator...........................................................18
STA®-VWF:Ag Calibrator .................................................18
STA-R® Family, STA Compact Max® and ........................ 7-8
STA Satellite® Disposables and Accessories
STA R Max® Hemostasis System.......................................3
Stachrom® Heparin..........................................................12
Stachrom® Heparin Cofactor II........................................33
Stachrom® PAI.................................................................32
Staclot® LA......................................................................14
Staclot® LA 20 ................................................................14
Staclot® VIIa-rTF..............................................................30
STart® Disposables and Accessories................................8
STart® Hemostasis Analyzer..............................................6
Test cards for D-Di Test kit...............................................15
Thrombin Calibrator.........................................................24
®
Notes
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
39
Notes
40
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
agenceL2R.com - ©2014 Diagnostica Stago - All rights reserved - Non-contractual photos - PROM-14-033 v A, Effective Date: 01/2016

Diagnostica Stago, Inc. Product Catalog 2016 - 3c

Transcription

Similar documents

Medizinische Austellung A4 Wien 2008.indd

`Nothing naked,` but just enough

Master Class Invitation - Majlis Bandaraya Petaling Jaya Aduan Online

No Ice Packs… EVER AGAIN! - FRIO Insulin Cooling Case

an interactive PDF of the map

Safety Complex Presentation to Budget Committee

MedDX Thermacor Rigid Secondary Absorbent Clamshell

Advertising on veletrhyavystavy.cz

Tsubasa TAKAHASHI Solo Show B o s h u ( G r a i n i n e a r )

54-69 ARCH